Showing results (1321-1330 of 1,420) with videos related to
Sort By:
Pageof 142
Cellular and Molecular Biology (Noisy-Le-Grand, France)|September 8, 2000
Targeting exposed RNA regions in crystals of the small ribosomal subunits at medium resolutionH Bartels, M Gluehmann, D Janell, et al.Plos One|May 14, 2013
Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonanceKenneth B Lewis, Richard J Hughes, Melinda S Epstein, et al.Molecular Cell|November 23, 2016
Metalloprotease SPRTN/DVC1 Orchestrates Replication-Coupled DNA-Protein Crosslink RepairBruno Vaz, Marta Popovic, Joseph A Newman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2016
Assessment of Total Lesion Glycolysis by <sup>18</sup>F FDG PET/CT Significantly Improves Prognostic Value of GEP and ISS in MyelomaJames E McDonald, Marcus M Kessler, Michael W Gardner, et al.Nature Communications|June 19, 2026
USP24 is a cross-reactive DUB targeting MOV10 to regulate IFN-I productionRishov Mukhopadhyay, Simeon D Draganov, Timo Oosenbrug, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 1999
Phenotypic expressions of CCR5-delta32/delta32 homozygosityG T Nguyêñ, M Carrington, J A Beeler, et al.Proceedings of the National Academy of Sciences of the United States of America|December 6, 2023
USP16 is an ISG15 cross-reactive deubiquitinase that targets pro-ISG15 and ISGylated proteins involved in metabolismJin Gan, Adán Pinto-Fernández, Dennis Flierman, et al.BMJ Open|October 1, 2021
Deep brain stimulation for locomotion in incomplete human spinal cord injury (DBS-SCI): protocol of a prospective one-armed multi-centre studyLennart H Stieglitz, Anna-Sophie Hofer, Marc Bolliger, et al.European Urology|February 3, 2016
Transcutaneous Electrical Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic ReviewTobias Gross, Marc P Schneider, Lucas M Bachmann, et al.Annals of Internal Medicine|January 7, 2015
D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort studyClive Kearon, Frederick A Spencer, Denis O'Keeffe, et al.Pageof 142